in

Mallinckrodt mulls restructuring as opioid trial nears; the next FDA commissioner will be … — BioPortfolio.com


10:21 EDT 5 Sep 2019 | STAT

HHS Secretary Alex Azar submitted three names to the White House as potential FDA commissioners.

Original Article: STAT Plus: Pharmalittle: Mallinckrodt mulls restructuring as opioid trial nears; the next FDA commissioner will be …

NEXT ARTICLE

More From BioPortfolio on “STAT Plus: Pharmalittle: Mallinckrodt mulls restructuring as opioid trial nears; the next FDA commissioner will be …”



Source link

What do you think?

0 points
Upvote Downvote

Written by admin

This is a health Site for information purposes only. Do not take any news as Medical Advice. Always consult with your Health professional. All contents are derived from their respective sources and under their warranty.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Loading…

0

Comments

0 comments

At Last, an Effective Oral Antidepressant with a Novel Mechanism of Action? — BioPortfolio.com

Spartan Bioscience Announces Publication of Landmark POPular Genetics Clinical Trial in the New England Journal of Medicine — BioPortfolio.com